CLINICAL_TRIALS trial_result · 2020-02-26

Clinical Trial Update: Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin [NA]

A completed clinical trial updating on the effects of a UESAD on laryngeal symptoms and salivary pepsin in laryngopharyngeal reflux.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Northwestern University | Conditions: Laryngopharyngeal Reflux | NA | Status: COMPLETED | Results posted: 2020-02-26